Comparing antigenaemia - and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa

Resource Type

Dataset

DOI

https://doi.org/10.48765/nxq0-6562

Funding

NTD Modelling Consortium by the Bill & Melinda Gates Foundation [OPP1184344, https://www.gatesfoundation.org]

Bill and Melinda Gates Foundation [OPPGH5342, https://www.gatesfoundation.org]

Dutch Research Council NOW [grant 016.Veni.178.023, https://www.nwo.nl/]

Description

Data collected from participants at four separate timepoints in Cote d'Ivoire and Liberia identified by a unique participant ID. There are four timepoints collected from each country: Baseline, Follow-up Year 1, Follow-Up Year 2, and Follow-up Year 3. Each dataset includes the participant ID, gender, age, the microfilarae (MF) count collected through blood smear, and circulating filarial antigen (CFA) result from a strip test.

Keywords

Lymphatic filariasis, elimination, mass drug administration, mathematical modelling, Ivermectin, albendazole, endpoints

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Publication Date

9-30-2022

Additional Files
data-dictionary-mda-liberia-cdi.csv (1 kB)
Data Dictionary
README (2)utf.txt (1 kB)
Description of available files
Link to Full Text

Share

COinS
 
 

Link to Published Version

Published Version